Literature DB >> 19122118

Dendritic cells differentiate into osteoclasts in bone marrow microenvironment in vivo.

Mawadda Alnaeeli, Yen-Tung A Teng.   

Abstract

Mesh：

Year:  2009        PMID： 19122118      PMCID： PMC2951833          DOI： 10.1182/blood-2008-09-180836

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo.

Authors:  G J Randolph; K Inaba; D F Robbiani; R M Steinman; W A Muller
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

2.  Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo.

Authors:  Brent A Hanks; Jianghong Jiang; Rana A K Singh; Weitao Song; Michael Barry; Mary H Huls; Kevin M Slawin; David M Spencer
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

Review 3.  Dendritic cells at the osteo-immune interface: implications for inflammation-induced bone loss.

Authors:  Mawadda Alnaeeli; Jaekweon Park; Deeqa Mahamed; Joseph M Penninger; Yen-Tung A Teng
Journal:  J Bone Miner Res       Date:  2007-06       Impact factor: 6.741

4.  Immune interactions with CD4+ T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells.

Authors:  Mawadda Alnaeeli; Josef M Penninger; Yen-Tung Andy Teng
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

5.  Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines.

Authors:  Carole Speziani; Aymeric Rivollier; Anne Gallois; Fabienne Coury; Marlène Mazzorana; Olga Azocar; Monique Flacher; Chantal Bella; Jacques Tebib; Pierre Jurdic; Chantal Rabourdin-Combe; Christine Delprat
Journal:  Eur J Immunol       Date:  2007-03       Impact factor: 5.532

6.  Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts.

Authors:  Abdelilah Wakkach; Anna Mansour; Romain Dacquin; Emmanuel Coste; Pierre Jurdic; Georges F Carle; Claudine Blin-Wakkach
Journal:  Blood       Date:  2008-09-02       Impact factor: 22.113

7.  Stimulation by toll-like receptors inhibits osteoclast differentiation.

Authors:  Masamichi Takami; Nacksung Kim; Jaerang Rho; Yongwon Choi
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

8.  In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.

Authors:  E Ingulli; A Mondino; A Khoruts; M K Jenkins
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307
  8 in total
  6 in total

Review 1.  Mediators of the inflammatory response to joint replacement devices.

Authors:  Neil Cobelli; Brian Scharf; Giovanna M Crisi; John Hardin; Laura Santambrogio
Journal:  Nat Rev Rheumatol       Date:  2011-09-06       Impact factor: 20.543

2.  Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.

Authors:  Anjli Kukreja; Soroosh Radfar; Ben-Hua Sun; Karl Insogna; Madhav V Dhodapkar
Journal:  Blood       Date:  2009-08-06       Impact factor: 22.113

3.  Involvement of SOCS3 in regulation of CD11c+ dendritic cell-derived osteoclastogenesis and severe alveolar bone loss.

Authors:  Xiaoxia Zhang; Mawadda Alnaeeli; Bhagirath Singh; Yen-Tung A Teng
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

4.  A T Cell View of the Bone Marrow.

Authors:  Adriana Bonomo; Ana Carolina Monteiro; Triciana Gonçalves-Silva; Eric Cordeiro-Spinetti; Rômulo Gonçalves Galvani; Alex Balduino
Journal:  Front Immunol       Date:  2016-05-17       Impact factor: 7.561

Review 5.  The Rising Era of "Immunoporosis": Role of Immune System in the Pathophysiology of Osteoporosis.

Authors:  Rupesh K Srivastava; Leena Sapra
Journal:  J Inflamm Res       Date:  2022-03-05

6.  Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis.

Authors:  Frédéric Grosjean; Sonia Nasi; Pascal Schneider; Véronique Chobaz; Alexandra Liu; Vanessa Mordasini; Kristell Moullec; Paolo Vezzoni; Christine Lavanchy; Nathalie Busso; Hans Acha-Orbea; Driss Ehirchiou
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.